Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News BD receives CE Mark approval for BD Max Vaginal Panel

BD receives CE Mark approval for BD Max Vaginal Panel

26th May 2016

BD has announced that the BD Max Vaginal Panel, its new in vitro diagnostic assay, has been granted European regulatory approval.

The CE Mark-approved device aims to provide laboratories and clinicians with the ability to use a single test to detect microorganisms responsible for bacterial vaginosis, candidiasis and trichomoniasis.

As with other BD Max System offerings, the new assay combines and automates real-time PCR extraction, amplification and detection into a single process.

This simplifies the process of identifying the common infectious causes of vaginitis, one of the most common conditions affecting women's health, with up to 75 percent of women experiencing at least one case of vaginitis or vaginosis in their lifetime.

Dr Patrick Murray, worldwide senior director of scientific affairs for diagnostic systems at BD Life Sciences, said: "The BD Max Vaginal Panel has the potential to help clinicians improve patient management and help laboratories increase workflow efficiency."

During the most recent fiscal quarter, the company experienced year-on-year growth of 49.7 percent, thanks to the positive impact of the recent acquisition of CareFusion.ADNFCR-8000103-ID-801819227-ADNFCR

We currently have 8 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.